Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency

Radiotherapy and Oncology

Volumn 97, Issue 3, 2010, Pages 488-494

  Rosenblatt, Eduardo ^a   Jones, Glenn ^b   Sur, Ranjan K ^c,d   Donde, Bernard ^e   Salvajoli, Joao V ^f   Ghosh Laskar, Sarbani ^g   Frobe, Ana ^h   Suleiman, Ahmed ⁱ   Xiao, Zefen ^j   Nag, Subir ^k  

^a INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d JURAVINSKI CANCER CENTRE   (Canada)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f A C CAMARGO CANCER CENTER   (Brazil)

^g TATA MEMORIAL HOSPITAL   (India)

^h UNIVERSITY OF ZAGREB   (Croatia)

ⁱ Radiation and Isotopes Centre   (Sudan)

^j PEKING UNION MEDICAL COLLEGE   (China)

^k KAISER PERMANENTE   (United States)

more..

Author keywords

Dysphagia; HDR brachytherapy; Oesophagus; Palliation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRACHYTHERAPY; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ODYNOPHAGIA; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY OF LIFE; RADIATION INJURIES; SURVIVAL RATE; YOUNG ADULT;

EID: 78651485781     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.001     Document Type: Article

References (29)

1. GLOBOCAN 2002 database, (http://www-dep.iarc.fr/ ) accessed November 2008.
2. J. Ferlay, D.M. Parkin, and P. Pisani Globocan 1: cancer incidence and mortality worldwide 1999 IARC Press Lyon
3. A. Herkovic, K. Martz, and M. Al Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
4. D. Cunningham, W.H. Allum, and S.P. Stenning Perioperative chemotherapy in operable and lower oesophageal cancer: final results of a randomized, controlled trial (the MAGIC trial, ISRCTN 93793971) ASCO presentation J Clin Oncol 23 2005 4001
5. R.K. Sur, B. Donde, C.V. Levin, and A. Mannell Fractionated high dose intraluminal brachytherapy in palliation of advanced esophageal cancer Int J Radiat Oncol Biol Phys 40 1998 447 453
6. Y. Hishikawa, N. Kamikonya, S. Tanaka, and T. Miura Radiotherapy of oesophageal carcinoma: role of high dose rate intracavitary irradiation Radiother Oncol 9 1987 13 20
7. R.K. Sur, C.V. Levin, and V. Sharma A prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal cancer. An IAEA study Int J Radiat Oncol Biol Phys 53 2002 127 133
8. M. Kulhavy, R.K. Sur, C.V. Levin, B. Donde, and F. Luhana Optimization of single fraction high dose rate intra-luminal brachytherapy in palliation of advanced oesophageal cancer: a preliminary report Endocuriether Hypertherm Oncol 11 1995 235 239
9. R. Fogaroli, J. Salvajoli, R. Ferrigno, P.E. Novaes, M.A. Conte-Maia, and A.C. Pellizon High dose brachytherapy for advanced thoracic oesophageal cancer in patients ineligible for chemoradiotherapy J Brachytherapy Int 17 2001 51 58
10. E.C. Hyden Ext beam and ILRT in the treatment of cancer of the oesophagus J Thorac Cardiovasc Surg 96 1988 237 241
11. M.Y. Homs, W.M. Eijkenboom, V.L. Coen, J. Haringsma, M. van Blankenstein, and E.J. Kuipers High dose rate brachytherapy for the palliation of malignant dysphagia Radiother Oncol 66 2003 327 332
12. V. Sharma, U. Mahantshetty, K.A. Dinshaw, R. Deshpande, and S. Sharma Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 52 2002 310 315
13. M. Javle, S. Ailawadhi, G.Y. Yang, C.E. Nwogu, M.D. Schiff, and H.R. Nava Palliation of malignant dysphagia in esophageal cancer: a literature-based review J Support Oncol 4 2006 365 373 379. Review
14. R.K. Sur, B. Donde, C.V. Levin, A. Mannell, and D. Van der Merwe Chemo sensitization and brachytherapy in palliation of advanced esophageal cancer J Brachytherapy Int 15 1999 177187
15. R.K. Sur, R. Kochhar, and P.S. Negi High dose rate intraluminal brachytherapy in palliation of oesophageal cancer Endocuriether Hypertherm Oncol 10 1994 25 29
16. R. Sur, B. Donde, C. Falkson, S.N. Ahmed, V. Levin, and S. Nag Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer Brachytherapy 3 2004 191 195
17. Rosenblatt E, Jones G, Sur R, et al. Adding external beam to HDR-BT improves palliation of oesophageal cancer: a prospective randomized multicentre trial of the IAEA.ECCO-14 meeting, abstract 3503. Eur J Cancer. 2007;5:260.
18. Nag S, Jones G, Sur R, et al. Does the addition of external beam to HDR intraluminal brachytherapy improve palliation oesophageal cancer?: a randomized international multi-institutional trial. ASTRO Annual Meeting abstract-191, 2007. Int J Radiat Oncol Biol Phys. 2007;69:S107.
19. M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, and E.T. McFadden Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 1982 649 655
20. R.K. Sur, B. Donde, C. Falkson, S.N. Ahmed, V. Levin, and S. Nag Randomized prospective study comparing high dose-rate intraluminal brachytherapy (HDRILBT) alone and HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer Brachytherapy 3 2004 191 195
21. R.K. Sur, V. Levin, F.F. Rad, B. Donde, V. Sharma, and L. Miszczyk Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma: an international atomic energy agency study Int J Radiat Oncol Biol Phys 53 2002 127 133
22. K.W. Knyrim, N. Bethge, M. Keymling, and N. Vakil A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer N Eng J Med 78 1993 1302 1307
23. Fayers PM, Machin D, Quality of life, 2nd ed., The assessment, analysis and interpretation of patient-reported outcomes, Chichester, UK: John Wiley & Sons; 2007 [Chapter 13].
24. N.E. Breslow, and D.G. Clayton Approximate inference in generalized linear mixed models J Am Stat Assoc 88 1993 9 25 JSTOR 2290687
25. B.D. Minsky, T.F. Pajak, R.J. Ginsberg, T.M. Pisansky, J. Martenson, and R. Komaki INT 0123 (RTOG 94-05) Phase III trial of combined modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
26. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 15:277-284.
27. R. Earlam, and J.R. Cunha-Melo Oesophageal squamous cell carcinomas: a critical view of radiotherapy Br J Surg 67 1980 457 461
28. M.Y.V. Homs, E.W. Steyerberg, and W.M.H. Eijkenboom Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomized trial Lancet 364 2004 1497 1504
29. "ClinicalTrials.gov". Protocol Registration Receipt 04/18/2008: Palliative radiotherapy and brachytherapy for oesophageal cancer dysphagia, 2008.